28 October 2020
Freemasons New Zealand have renewed their support of the Institute’s CAR T-cell programme, pledging a further $600,000 over the next three years.
Freemasons New Zealand Grand Master Graham Wrigley says Freemasons New Zealand are proud to continue to support the Institute’s work because it is practical research that will have real outcomes that have the potential to improve the lives of all New Zealanders.
“Freemasons New Zealand donate extensively to medical research programmes like this CAR T-cell research because they are a promising and effective way that we can do something tangible to help New Zealanders. Our support is motivated by the guiding principles that underpin Freemasonry, particularly compassion and love of, and support for, humankind.”
Director of the Malaghan Institute professor Graham Le Gros says the financial partnership with the Freemasons provides a significant and vital boost to the Institute’s CAR T-cell research.
“As an independent research organisation and charity, the Malaghan Institute relies on support from the community and the generosity of organisations like Freemasons whose support, along with that of other organisations, will allow us to accelerate the availability of this ground-breaking treatment in New Zealand.”
Professor Mike Berridge: winner of the Shorland Medal
15 November 2021
Taking RNA technology into NZ’s future
19 October 2021
New partnership to scale up CAR T-cell cancer treatment in New Zealand
23 September 2021
Building better CAR T-cell technology
3 May 2021
Improving cancer immunotherapies through hypoxia-activated drugs
20 October 2020
A return to normal: Clinical trials full steam ahead
15 July 2020